These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 16772768

  • 1. Phenothiazine molecule provides the basic chemical structure for various classes of pharmacotherapeutic agents.
    Mosnaim AD, Ranade VV, Wolf ME, Puente J, Antonieta Valenzuela M.
    Am J Ther; 2006; 13(3):261-73. PubMed ID: 16772768
    [Abstract] [Full Text] [Related]

  • 2. In vitro human plasma leucine(5)-enkephalin degradation is inhibited by a select number of drugs with the phenothiazine molecule in their chemical structure.
    Mosnaim AD, Puente J, Saavedra R, Diamond S, Wolf ME.
    Pharmacology; 2003 Jan; 67(1):6-13. PubMed ID: 12444298
    [Abstract] [Full Text] [Related]

  • 3. Recent progress in biological activities of synthesized phenothiazines.
    Pluta K, Morak-Młodawska B, Jeleń M.
    Eur J Med Chem; 2011 Aug; 46(8):3179-89. PubMed ID: 21620536
    [Abstract] [Full Text] [Related]

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 5. Bacitracin-sensitive aminopeptidase(s) degradation of methionine(5)-enkephalin by human brain putamen and hippocampus preparations: inhibition by phenothiazine drugs.
    Mosnaim AD, Saavedra R, Wolf ME.
    Am J Ther; 2009 Dec; 16(6):512-6. PubMed ID: 19797941
    [Abstract] [Full Text] [Related]

  • 6. [New biological properties of neuroleptic phenothiazines].
    Morak-Młodawska B, Jeleń M.
    Pol Merkur Lekarski; 2007 Dec; 23(138):459-61. PubMed ID: 18432132
    [Abstract] [Full Text] [Related]

  • 7. Relationship between pi-electron distribution and anticancer activity of benzo[a]phenothiazines.
    Motohashi N, Sasaki Y, Wakabayashi Y, Sakagami H, Molnar J, Kurihara T.
    Anticancer Res; 1992 Dec; 12(5):1423-6. PubMed ID: 1444201
    [Abstract] [Full Text] [Related]

  • 8. Neither lipophilicity nor membrane-perturbing potency of phenothiazine maleates correlate with the ability to inhibit P-glycoprotein transport activity.
    Hendrich AB, Wesołowska O, Poła A, Motohashi N, Molnár J, Michalak K.
    Mol Membr Biol; 2003 Dec; 20(1):53-60. PubMed ID: 12745926
    [Abstract] [Full Text] [Related]

  • 9. Multiple non-psychiatric effects of phenothiazines: a review.
    Sudeshna G, Parimal K.
    Eur J Pharmacol; 2010 Dec 01; 648(1-3):6-14. PubMed ID: 20828548
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and biochemical characterization of new phenothiazines and related drugs as MDR reversal agents.
    Schmidt M, Teitge M, Castillo ME, Brandt T, Dobner B, Langner A.
    Arch Pharm (Weinheim); 2008 Oct 01; 341(10):624-38. PubMed ID: 18816589
    [Abstract] [Full Text] [Related]

  • 11. [Effect of phenothiazine and butyrophenone derivatives on the development of toxic brain edema].
    Platonov IA, Iasnetsov VS.
    Farmakol Toksikol; 1981 Oct 01; 44(5):565-7. PubMed ID: 6118290
    [No Abstract] [Full Text] [Related]

  • 12. Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives.
    Bisi A, Meli M, Gobbi S, Rampa A, Tolomeo M, Dusonchet L.
    Bioorg Med Chem; 2008 Jul 01; 16(13):6474-82. PubMed ID: 18522868
    [Abstract] [Full Text] [Related]

  • 13. Radical intensity and differentiation-inducing activity of benzo[a]phenothiazines and phenothiazines.
    Satoh K, Sakagami H, Kurihara T, Motohashi N.
    Anticancer Res; 1997 Jul 01; 17(4A):2465-9. PubMed ID: 9252664
    [Abstract] [Full Text] [Related]

  • 14. Chemical structure of phenothiazines and their biological activity.
    Jaszczyszyn A, Gąsiorowski K, Świątek P, Malinka W, Cieślik-Boczula K, Petrus J, Czarnik-Matusewicz B.
    Pharmacol Rep; 2012 Jul 01; 64(1):16-23. PubMed ID: 22580516
    [Abstract] [Full Text] [Related]

  • 15. Comparative study of phenothiazine derivatives on monoamine metabolism--direct correlation between the concentrations of drugs and monoamine metabolites in the brain.
    Shibanoki S, Kubo T, Ishikawa K.
    J Pharmacol Exp Ther; 1987 Mar 01; 240(3):959-65. PubMed ID: 2882017
    [Abstract] [Full Text] [Related]

  • 16. [New derivatives of phenothiazines with anticancer activities].
    Morak-Młodawska B, Jeleń M, Pluta K.
    Pol Merkur Lekarski; 2009 Jun 01; 26(156):671-5. PubMed ID: 19711740
    [Abstract] [Full Text] [Related]

  • 17. Relationship between tumor (T) antigen expression and substituent effects on benzo [a] phenothiazines.
    Pusztai R, Motohashi N, Párkányi C, Aaron JJ, Rao BK, Molnár J.
    Anticancer Res; 1996 Jun 01; 16(5A):2961-4. PubMed ID: 8917413
    [Abstract] [Full Text] [Related]

  • 18. Essential structural features of novel antischizophrenic drugs: a review.
    Nematollahi A, Aminimoghadamfarouj N, Church WB.
    Med Chem; 2014 Jun 01; 10(6):541-9. PubMed ID: 24372388
    [Abstract] [Full Text] [Related]

  • 19. Phenothiazine: the seven lives of pharmacology's first lead structure.
    Ohlow MJ, Moosmann B.
    Drug Discov Today; 2011 Feb 01; 16(3-4):119-31. PubMed ID: 21237283
    [Abstract] [Full Text] [Related]

  • 20. [Application of pharmacotherapy with classic neuroleptics: phenothiazine derivatives in schizophrenia].
    Kleszczewska E, Hejza J.
    Pol Merkur Lekarski; 2003 Feb 01; 14(80):136-8. PubMed ID: 12728674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.